Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Return on Invested Capital (2020 - 2024)

Revolution Medicines has reported Return on Invested Capital over the past 5 years, most recently at 0.25% for Q4 2024.

  • Quarterly results put Return on Invested Capital at 0.25% for Q4 2024, up 11.0% from a year ago — trailing twelve months through Dec 2024 was 0.25% (up 11.0% YoY), and the annual figure for FY2024 was 0.24%, up 15.0%.
  • Return on Invested Capital for Q4 2024 was 0.25% at Revolution Medicines, up from 0.41% in the prior quarter.
  • Over the last five years, Return on Invested Capital for RVMD hit a ceiling of 0.2% in Q2 2021 and a floor of 0.42% in Q3 2022.
  • Median Return on Invested Capital over the past 5 years was 0.31% (2024), compared with a mean of 0.31%.
  • Biggest five-year swings in Return on Invested Capital: decreased -17bps in 2022 and later increased 11bps in 2024.
  • Revolution Medicines' Return on Invested Capital stood at 0.23% in 2020, then dropped by -14bps to 0.26% in 2021, then crashed by -65bps to 0.42% in 2022, then rose by 13bps to 0.37% in 2023, then soared by 31bps to 0.25% in 2024.
  • The last three reported values for Return on Invested Capital were 0.25% (Q4 2024), 0.41% (Q3 2024), and 0.36% (Q2 2024) per Business Quant data.